96 related articles for article (PubMed ID: 2417888)
1. Decrease in acetylcholine-receptor content of human myotube cultures mediated by monoclonal antibodies to alpha, beta and gamma subunits.
Tzartos SJ; Starzinski-Powitz A
FEBS Lett; 1986 Feb; 196(1):91-5. PubMed ID: 2417888
[TBL] [Abstract][Full Text] [Related]
2. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
Tzartos SJ; Sophianos D; Zimmerman K; Starzinski-Powitz A
J Immunol; 1986 May; 136(9):3231-8. PubMed ID: 3958494
[TBL] [Abstract][Full Text] [Related]
3. Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis.
Lindstrom J; Einarson B
Muscle Nerve; 1979; 2(3):173-9. PubMed ID: 503104
[TBL] [Abstract][Full Text] [Related]
4. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
Tzartos SJ; Sophianos D; Efthimiadis A
J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
[TBL] [Abstract][Full Text] [Related]
5. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
Loutrari H; Tzartos SJ; Claudio T
Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157
[TBL] [Abstract][Full Text] [Related]
6. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera.
Sophianos D; Tzartos SJ
J Autoimmun; 1989 Dec; 2(6):777-89. PubMed ID: 2619869
[TBL] [Abstract][Full Text] [Related]
7. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
Loutrari H; Kokla A; Trakas N; Tzartos SJ
Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
[TBL] [Abstract][Full Text] [Related]
8. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome.
Lindstrom JM; Lambert EH
Neurology; 1978 Feb; 28(2):130-8. PubMed ID: 202890
[No Abstract] [Full Text] [Related]
9. Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis.
Merlie JP; Heinemann S; Einarson B; Lindstrom JM
J Biol Chem; 1979 Jul; 254(14):6328-32. PubMed ID: 447717
[TBL] [Abstract][Full Text] [Related]
10. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.
Drachman DB; Angus CW; Adams RN; Michelson JD; Hoffman GJ
N Engl J Med; 1978 May; 298(20):1116-22. PubMed ID: 643030
[TBL] [Abstract][Full Text] [Related]
11. Structure and function of the acetylcholine receptor molecule studied using monoclonal antibodies.
Lindstrom J; Tzartos S; Gullick W
Ann N Y Acad Sci; 1981; 377():1-19. PubMed ID: 6176164
[No Abstract] [Full Text] [Related]
12. Effect of sera from myasthenia gravis patients on acetylcholine receptors in myotube cultures.
Hudgson P; McAdams MW; Pericak-Vance MA; Edwards TM; Roses AD
J Neurol Sci; 1983 Apr; 59(1):37-45. PubMed ID: 6854343
[No Abstract] [Full Text] [Related]
13. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
14. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
[TBL] [Abstract][Full Text] [Related]
15. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines.
Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S
Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholine receptor: molecular dissection and monoclonal antibodies in the study of experimental myasthenia.
Fuchs S; Bartfeld D; Mochly-Rosen D; Souroujon M; Feingold C
Ann N Y Acad Sci; 1981; 377():110-24. PubMed ID: 6176165
[No Abstract] [Full Text] [Related]
17. Antibody-induced degradation of acetylcholine receptor in myasthenia gravis: clinical correlates and pathogenetic significance.
Tronconi BC; Brigonzi A; Fumagalli G; Sher M; Cosi V; Piccolo G; Clementi F
Neurology; 1981 Nov; 31(11):1440-4. PubMed ID: 7198191
[TBL] [Abstract][Full Text] [Related]
18. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit.
Melms A; Malcherek G; Gern U; Wiethölter H; Müller CA; Schoepfer R; Lindstrom J
Ann Neurol; 1992 Mar; 31(3):311-8. PubMed ID: 1379027
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits.
Tzartos SJ; Lindstrom JM
Proc Natl Acad Sci U S A; 1980 Feb; 77(2):755-9. PubMed ID: 6153804
[TBL] [Abstract][Full Text] [Related]
20. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
Drachman DB; Angus CW; Adams RN; Kao I
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3422-6. PubMed ID: 277944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
